SCHEMBL7682696

SCHEMBL7682696

CCOCCC1=NN=C(c2cccnc2)[N]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.40
CYP19A1 P11511 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2D6 P10635 2/20 0.40
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CYP2A6 P11509 5/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 1/20 0.38
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
MYC P01106 1/20 0.35
CYP2E1 P05181 2/20 0.35
CYP2B6 P20813 2/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678740 0.86 CYP2A6 (0.40) CYP3A4CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7676360 0.86 CYP2A6 (0.40) CYP3A4CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7676187 0.81 CYP2A6 (0.47) CYP3A4CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7673942 0.78 CYP2A6 (0.44) CYP3A4CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7679937 0.75 NPC1 (0.48) CYP3A4CYP2C9CYP2C19CYP2D6CYP11B1
SCHEMBL7674967 0.74 MKNK1 (0.50) CYP3A4CYP2C9CYP2C19CYP2D6CYP2A6
SCHEMBL7674216 0.74 CYP2A6 (0.50) CYP3A4CYP2C9CYP2C19CYP2D6CYP2A6
SCHEMBL7680165 0.72 TBXAS1 (0.51)
SCHEMBL7673098 0.72 KMT2A (0.43) CYP3A4CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7683444 0.71 CYP2A6 (0.37) CYP3A4CYP11B1CYP11B2CYP2A6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed